Jennifer M. Phillips
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jennifer M. Phillips has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Y. Hardan
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, USA
2 shared publications - Daniel Arthur Abrams
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine
2 shared publications - Joseph P. Garner
Department of Comparative Medicine, Stanford University, Stanford, USA
2 shared publications - Karen J. Parker
Department of Psychiatry and Behavioral Sciences Stanford University Stanford California USA
2 shared publications - Ozge Oztan
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305
2 shared publications - Raena D. Sumiyoshi
Department of Psychiatry and Behavioral Sciences Stanford University Stanford California
2 shared publications
Latest Publications
- Open Access
- 13 July 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (29)
Developmental divergence in voice–reward circuitry differentiates autistic from typically developing children and adolescents
Adolescence is a period of profound social change marked by a developmental shift in attention and motivation from parents toward nonfamilial peers. Autism is a neurodevelopmental condition characterized by lifelong challenges in social communication. However, the neurobiological signatures of adolescent social reorientation in autism are poorly understood. Human voice processing is a primary driver of social learning and communication, but it remains understudied in the autism literature, particularly as it relates to neurodevelopmental change. Here we used functional brain imaging of voice processing in children and adolescents with autism and matched controls (ages 7 to 17) to examine neural responses to mother’s voice and nonfamilial voices. We identified divergent age-related patterns in autism across reward, salience, social evaluative, and frontoparietal processing regions consistent with models of an extended voice processing network. Results showed that while typically developing participants exhibited age-related increases in neural activity and connectivity within regions of the voice processing network, individuals with autism showed no age-related increases, and often decreases, in these regions. Adolescents with autism further revealed a reversal of the characteristic developmental pattern: with increasing age, they exhibited decreasing neural engagement with nonfamilial voices and increasing engagement with mother’s voice, a pattern that was most pronounced in individuals with more severe social communication challenges. Findings suggest that disrupted organization of the extended voice processing network, including reward, salience, social evaluative, and frontoparietal circuitry, may underlie atypical social neurodevelopment in autism. More broadly, results suggest that individual differences in social communication shape age-related neural patterns supporting social reorientation.
- 13 July 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (29)
Open AccessDevelopmental divergence in voice–reward circuitry differentiates autistic from typically developing children and adolescents
Adolescence is a period of profound social change marked by a developmental shift in attention and motivation from parents toward nonfamilial peers. Autism is a neurodevelopmental condition characterized by lifelong challenges in social communication. However, the neurobiological signatures of adolescent social reorientation in autism are poorly understood. Human voice processing is a primary driver of social learning and communication, but it remains understudied in the autism literature, particularly as it relates to neurodevelopmental change. Here we used functional brain imaging of voice processing in children and adolescents with autism and matched controls (ages 7 to 17) to examine neural responses to mother’s voice and nonfamilial voices. We identified divergent age-related patterns in autism across reward, salience, social evaluative, and frontoparietal processing regions consistent with models of an extended voice processing network. Results showed that while typically developing participants exhibited age-related increases in neural activity and connectivity within regions of the voice processing network, individuals with autism showed no age-related increases, and often decreases, in these regions. Adolescents with autism further revealed a reversal of the characteristic developmental pattern: with increasing age, they exhibited decreasing neural engagement with nonfamilial voices and increasing engagement with mother’s voice, a pattern that was most pronounced in individuals with more severe social communication challenges. Findings suggest that disrupted organization of the extended voice processing network, including reward, salience, social evaluative, and frontoparietal circuitry, may underlie atypical social neurodevelopment in autism. More broadly, results suggest that individual differences in social communication shape age-related neural patterns supporting social reorientation.
- Open Access
- 3 July 2023
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 63 (1) , 65-79
A Twin Study of Altered White Matter Heritability in Youth With Autism Spectrum Disorder
- 3 July 2023
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 63 (1) , 65-79
Open AccessA Twin Study of Altered White Matter Heritability in Youth With Autism Spectrum Disorder
- 12 December 2022
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 62 (5) , 568-581
Dimensional Assessment of Restricted and Repetitive Behaviors: Development and Preliminary Validation of a New Measure
- 12 December 2022
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 62 (5) , 568-581
Dimensional Assessment of Restricted and Repetitive Behaviors: Development and Preliminary Validation of a New Measure
- 17 November 2022
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 46 (3)
Sleep architecture is associated with core symptom severity in autism spectrum disorder
Study Objectives: While caregiver-reported sleep disturbances are common in children and adolescents with autism spectrum disorder ([‘), few studies have measured objective sleep in ASD compared to controls, and their findings are mixed. We investigated (1) differences in sleep architecture, specifically slow-wave sleep (SWS) and rapid eye movement (REM) sleep, between ASD and typically developing controls (TD); and (2) if any observed differences in sleep were associated with core ASD symptoms.Methods: We used ambulatory polysomnography (PSG) in 53 participants with ASD (ages 4–18) and 66 age-matched TD in their home sleeping environment. The primary outcome measures were SWS and REM sleep. Core behavioral ASD symptoms were assessed using the Autism Diagnostic Interview-Revised (ADI-R). Spectral power bands during sleep, and additional behavioral measures, were examined in exploratory analyses.Results: Compared to TD, participants with ASD exhibited a higher SWS ratio and lower REM sleep ratio. Within the ASD group, higher SWS was associated with more severe symptoms on the Restricted, Repetitive, and Stereotyped Behaviors subscale of the ADI-R. No association was observed between REM sleep ratio and any ASD symptom.Conclusions: Increased SWS and reduced REM sleep ratio differentiated ASD from TD. However, only increased SWS was associated with more severe core ASD symptoms. Increased SWS may reflect neuronal immaturity specific to ASD in this age group. These findings may inform the underlying mechanisms of clinical symptoms observed in children and adolescents with ASD.
- 17 November 2022
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 46 (3)
Sleep architecture is associated with core symptom severity in autism spectrum disorder
Study Objectives: While caregiver-reported sleep disturbances are common in children and adolescents with autism spectrum disorder ([‘), few studies have measured objective sleep in ASD compared to controls, and their findings are mixed. We investigated (1) differences in sleep architecture, specifically slow-wave sleep (SWS) and rapid eye movement (REM) sleep, between ASD and typically developing controls (TD); and (2) if any observed differences in sleep were associated with core ASD symptoms.Methods: We used ambulatory polysomnography (PSG) in 53 participants with ASD (ages 4–18) and 66 age-matched TD in their home sleeping environment. The primary outcome measures were SWS and REM sleep. Core behavioral ASD symptoms were assessed using the Autism Diagnostic Interview-Revised (ADI-R). Spectral power bands during sleep, and additional behavioral measures, were examined in exploratory analyses.Results: Compared to TD, participants with ASD exhibited a higher SWS ratio and lower REM sleep ratio. Within the ASD group, higher SWS was associated with more severe symptoms on the Restricted, Repetitive, and Stereotyped Behaviors subscale of the ADI-R. No association was observed between REM sleep ratio and any ASD symptom.Conclusions: Increased SWS and reduced REM sleep ratio differentiated ASD from TD. However, only increased SWS was associated with more severe core ASD symptoms. Increased SWS may reflect neuronal immaturity specific to ASD in this age group. These findings may inform the underlying mechanisms of clinical symptoms observed in children and adolescents with ASD.
- Open Access
- 27 May 2019
- Published by Wiley in Autism Research
- Vol. 12 (8) , 1156-1161
Blood oxytocin concentration positively predicts contagious yawning behavior in children with autism spectrum disorder
Research suggests that children with autism spectrum disorder (ASD) may have reduced empathy, as measured by an impaired contagious yawn response, compared to typically developing (TD) children. Other research has failed to replicate this finding, instead attributing this phenomenon to group differences in attention paid to yawn stimuli. A third possibility is that only a subgroup of children with ASD exhibits the impaired contagious yawn response, and that it can be identified biologically. Here we quantified blood concentrations of the “social” neuropeptide oxytocin (OXT) and evaluated yawning behavior and attention rates during a laboratory task in children with ASD (N = 34) and TD children (N = 30) aged 6–12 years. No group difference in contagious yawning behavior was found. However, a blood OXT concentration × group (ASD vs. TD) interaction positively predicted contagious yawning behavior (F1,50 = 7.4987; P = 0.0085). Specifically, blood OXT concentration was positively related to contagious yawning behavior in children with ASD, but not in TD children. This finding was not due to delayed perception of yawn stimuli and was observed whether attention paid to test stimuli and clinical symptom severity were included in the analysis or not. These findings suggest that only a biologically defined subset of children with ASD exhibits reduced empathy, as measured by the impaired contagious yawn response, and that prior conflicting reports of this behavioral phenomenon may be attributable, at least in part, to variable mean OXT concentrations across different ASD study cohorts. Autism Res 2019, 12: 1156–1161. © 2019 International Society for Autism Research, Wiley Periodicals, Inc.Lay Summary: People with autism may contagiously yawn (i.e., yawn in response to another's yawn) less often than people without autism. We find that people with autism who have lower levels of blood oxytocin (OXT), a hormone involved in social behavior and empathy, show decreased contagious yawning, but those who have higher blood OXT levels do not differ in contagious yawning from controls. This suggests that decreased contagious yawning may only occur in a biologically defined subset of people with autism.
- 27 May 2019
- Published by Wiley in Autism Research
- Vol. 12 (8) , 1156-1161
Open AccessBlood oxytocin concentration positively predicts contagious yawning behavior in children with autism spectrum disorder
Research suggests that children with autism spectrum disorder (ASD) may have reduced empathy, as measured by an impaired contagious yawn response, compared to typically developing (TD) children. Other research has failed to replicate this finding, instead attributing this phenomenon to group differences in attention paid to yawn stimuli. A third possibility is that only a subgroup of children with ASD exhibits the impaired contagious yawn response, and that it can be identified biologically. Here we quantified blood concentrations of the “social” neuropeptide oxytocin (OXT) and evaluated yawning behavior and attention rates during a laboratory task in children with ASD (N = 34) and TD children (N = 30) aged 6–12 years. No group difference in contagious yawning behavior was found. However, a blood OXT concentration × group (ASD vs. TD) interaction positively predicted contagious yawning behavior (F1,50 = 7.4987; P = 0.0085). Specifically, blood OXT concentration was positively related to contagious yawning behavior in children with ASD, but not in TD children. This finding was not due to delayed perception of yawn stimuli and was observed whether attention paid to test stimuli and clinical symptom severity were included in the analysis or not. These findings suggest that only a biologically defined subset of children with ASD exhibits reduced empathy, as measured by the impaired contagious yawn response, and that prior conflicting reports of this behavioral phenomenon may be attributable, at least in part, to variable mean OXT concentrations across different ASD study cohorts. Autism Res 2019, 12: 1156–1161. © 2019 International Society for Autism Research, Wiley Periodicals, Inc.Lay Summary: People with autism may contagiously yawn (i.e., yawn in response to another's yawn) less often than people without autism. We find that people with autism who have lower levels of blood oxytocin (OXT), a hormone involved in social behavior and empathy, show decreased contagious yawning, but those who have higher blood OXT levels do not differ in contagious yawning from controls. This suggests that decreased contagious yawning may only occur in a biologically defined subset of people with autism.
- Top Cited PapersOpen Access
- 8 May 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (491)
A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism
The social impairments of autism spectrum disorder (ASD) have a major impact on quality of life, yet there are no medications that effectively treat these core social behavior deficits. Preclinical research suggests that arginine vasopressin (AVP), a neuropeptide involved in promoting mammalian social behaviors, may be a possible treatment for ASD. Using a double-blind, randomized, placebo-controlled, parallel study design, we tested the efficacy and tolerability of a 4-week intranasal AVP daily treatment in 30 children with ASD. AVP-treated participants aged 6 to 9.5 years received the maximum daily target dose of 24 International Units (IU); participants aged 9.6 to 12.9 years received the maximum daily target dose of 32 IU. Intranasal AVP treatment compared to placebo enhanced social abilities as assessed by change from baseline in this phase 2 trial’s primary outcome measure, the Social Responsiveness Scale, 2nd Edition total score (SRS-2 T score; F1,20 = 9.853; P = 0.0052; ηp2 = 33.0%; Cohen’s d = 1.40). AVP treatment also diminished anxiety symptoms and some repetitive behaviors. Most of these findings were more pronounced when we accounted for pretreatment AVP concentrations in blood. AVP was well tolerated with minimal side effects. No AVP-treated participants dropped out of the trial, and there were no differences in the rate of adverse events reported between treatment conditions. Last, no changes from baseline were observed in vital signs, electrocardiogram tracings, height and body weight, or clinical chemistry measurements after 4 weeks of AVP treatment. These preliminary findings suggest that AVP has potential for treating social impairments in children with ASD.
- 8 May 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (491)
Top Cited PapersOpen AccessA randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism
The social impairments of autism spectrum disorder (ASD) have a major impact on quality of life, yet there are no medications that effectively treat these core social behavior deficits. Preclinical research suggests that arginine vasopressin (AVP), a neuropeptide involved in promoting mammalian social behaviors, may be a possible treatment for ASD. Using a double-blind, randomized, placebo-controlled, parallel study design, we tested the efficacy and tolerability of a 4-week intranasal AVP daily treatment in 30 children with ASD. AVP-treated participants aged 6 to 9.5 years received the maximum daily target dose of 24 International Units (IU); participants aged 9.6 to 12.9 years received the maximum daily target dose of 32 IU. Intranasal AVP treatment compared to placebo enhanced social abilities as assessed by change from baseline in this phase 2 trial’s primary outcome measure, the Social Responsiveness Scale, 2nd Edition total score (SRS-2 T score; F1,20 = 9.853; P = 0.0052; ηp2 = 33.0%; Cohen’s d = 1.40). AVP treatment also diminished anxiety symptoms and some repetitive behaviors. Most of these findings were more pronounced when we accounted for pretreatment AVP concentrations in blood. AVP was well tolerated with minimal side effects. No AVP-treated participants dropped out of the trial, and there were no differences in the rate of adverse events reported between treatment conditions. Last, no changes from baseline were observed in vital signs, electrocardiogram tracings, height and body weight, or clinical chemistry measurements after 4 weeks of AVP treatment. These preliminary findings suggest that AVP has potential for treating social impairments in children with ASD.
- Open Access
- 26 February 2019
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 8
Impaired voice processing in reward and salience circuits predicts social communication in children with autism
Engaging with vocal sounds is critical for children’s social-emotional learning, and children with autism spectrum disorder (ASD) often ‘tune out’ voices in their environment. Little is known regarding the neurobiological basis of voice processing and its link to social impairments in ASD. Here, we perform the first comprehensive brain network analysis of voice processing in children with ASD. We examined neural responses elicited by unfamiliar voices and mother’s voice, a biologically salient voice for social learning, and identified a striking relationship between social communication abilities in children with ASD and activation in key structures of reward and salience processing regions. Functional connectivity between voice-selective and reward regions during voice processing predicted social communication in children with ASD and distinguished them from typically developing children. Results support the Social Motivation Theory of ASD by showing reward system deficits associated with the processing of a critical social stimulus, mother’s voice, in children with ASD.Editorial note: This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor's assessment is that minor issues remain unresolved (see decision letter).
- 26 February 2019
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 8
Open AccessImpaired voice processing in reward and salience circuits predicts social communication in children with autism
Engaging with vocal sounds is critical for children’s social-emotional learning, and children with autism spectrum disorder (ASD) often ‘tune out’ voices in their environment. Little is known regarding the neurobiological basis of voice processing and its link to social impairments in ASD. Here, we perform the first comprehensive brain network analysis of voice processing in children with ASD. We examined neural responses elicited by unfamiliar voices and mother’s voice, a biologically salient voice for social learning, and identified a striking relationship between social communication abilities in children with ASD and activation in key structures of reward and salience processing regions. Functional connectivity between voice-selective and reward regions during voice processing predicted social communication in children with ASD and distinguished them from typically developing children. Results support the Social Motivation Theory of ASD by showing reward system deficits associated with the processing of a critical social stimulus, mother’s voice, in children with ASD.Editorial note: This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor's assessment is that minor issues remain unresolved (see decision letter).